Cargando…

Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma

BACKGROUND: Immune checkpoint blockades (ICBs) are a promising treatment for cancers such as melanoma by blocking important inhibitory pathways that enable tumor cells to evade immune attack. Programmed death ligand 1 monoclonal antibodies (aPDL1s) can be used as an ICB to significantly enhance the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hei, Yu, Teng, Binhong, Zeng, Ziqian, Zhang, Siqi, Li, Qian, Pan, Jijia, Luo, Zuyuan, Xiong, Chunyang, Wei, Shicheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082626/ https://www.ncbi.nlm.nih.gov/pubmed/32214807 http://dx.doi.org/10.2147/IJN.S225807

Ejemplares similares

Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model
por: Merino, María, et al.
Publicado: (2021)

Targeting immunoliposomes to EGFR-positive glioblastoma
por: Kasenda, B., et al.
Publicado: (2022)

Immunoliposomes for detection of rupture-prone intracranial aneurysms
por: Jahromi, Behnam Rezai, et al.
Publicado: (2023)

Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody
por: Saeed, Mesha, et al.
Publicado: (2016)

Immunoliposomes doubly targeted to transferrin receptor and to α-synuclein
por: Loureiro, Joana A, et al.
Publicado: (2015)

Editorial: Understanding Gamma Delta T Cell Multifunctionality - Towards Immunotherapeutic Applications
por: Gustafsson, Kenth, et al.
Publicado: (2020)

Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma
por: Li, Ying, et al.
Publicado: (2014)

Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine
por: Noble, Charles O., et al.
Publicado: (2009)

Immunoliposome-based fluorometric patulin assay by using immunomagnetic nanoparticles
por: Song, Xinjie, et al.
Publicado: (2019)

Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer
por: Bazhin, Alexandr V, et al.
Publicado: (2013)

Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma
por: Morandi, Fabio, et al.
Publicado: (2018)

Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo.
por: Vingerhoeds, M. H., et al.
Publicado: (1996)

Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors
por: Urbán, Patricia, et al.
Publicado: (2011)

Proof-of-concept in vivo evaluation of targeted therapeutics: lessons from immunoliposomes
por: Benz, CC
Publicado: (2003)

Immunoliposome-PCR: a generic ultrasensitive quantitative antigen detection system
por: He, Junkun, et al.
Publicado: (2012)

Construction and characterization of immunoliposomes targeting fibroblast growth factor receptor 3
por: Zheng, Zhong, et al.
Publicado: (2019)

Evaluation of Targeted Delivery to the Brain Using Magnetic Immunoliposomes and Magnetic Force
por: Thomsen, Louiza Bohn, et al.
Publicado: (2019)

Novel method for screening functional antibody with comprehensive analysis of its immunoliposome
por: Hamamichi, Shusei, et al.
Publicado: (2021)

TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
por: Bertrand, Florie, et al.
Publicado: (2017)

Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression
por: Jain, Prateek, et al.
Publicado: (2023)

A Review of Immunotherapeutic Strategies in Canine Malignant Melanoma
por: Almela, Ramón M., et al.
Publicado: (2019)

Is Root Catalase a Bifunctional Catalase-Peroxidase?
por: Chioti, Vasileia, et al.
Publicado: (2017)

Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells
por: Koning, G A, et al.
Publicado: (1999)

Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes
Publicado: (1985)

Urea immunoliposome inhibits human vascular endothelial cell proliferation for hemangioma treatment
por: Wang, Zhiliang, et al.
Publicado: (2013)

Multifunctional nanostructures: Intelligent design to overcome biological barriers
por: Azizi, Mehdi, et al.
Publicado: (2023)

Creation of Lung-Targeted Dexamethasone Immunoliposome and Its Therapeutic Effect on Bleomycin-Induced Lung Injury in Rats
por: Chen, Xue-Yuan, et al.
Publicado: (2013)

Mechanisms of action underlying the immunotherapeutic activity of Allovectin in advanced melanoma
por: Doukas, J, et al.
Publicado: (2012)

The Immunotherapeutic Role of Type I and III Interferons in Melanoma and Non-Melanoma Skin Cancers
por: Weir, Sydney A., et al.
Publicado: (2023)

SPECTROSCOPY OF CATALASE
por: Stern, Kurt G.
Publicado: (1937)

Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner
por: Hosokawa, S, et al.
Publicado: (2003)

Docetaxel–trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer
por: Rodallec, Anne, et al.
Publicado: (2018)

Immunoliposomes-mediated small interfering RNA therapy: A novel approach for the treatment of cancer
por: Khan, Arif
Publicado: (2019)

Targeting Ovarian Cancer Cells Overexpressing CD44 with Immunoliposomes Encapsulating Glycosylated Paclitaxel
por: Khayrani, Apriliana Cahya, et al.
Publicado: (2019)

Production of glycosylphosphatidylinositol-anchored proteins for vaccines and directed binding of immunoliposomes to specific cell types
por: Fotoran, Wesley L., et al.
Publicado: (2020)

Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome
por: Houshmand, Mohammad, et al.
Publicado: (2021)

Effect of phospholipid head group on ultrasound-triggered drug release and cellular uptake of immunoliposomes
por: Awad, Nahid S., et al.
Publicado: (2023)

Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma
por: Yan, Huiyu, et al.
Publicado: (2023)

Ex Vivo Derived Primary Melanoma Cells: Implications for Immunotherapeutic Vaccines
por: Suriano, Robert, et al.
Publicado: (2013)

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
por: Wolchok, Jedd D, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2mji1eriaipmqfgn2lrgpp3bp4